The Emerging Role of MicroRNA-155 in Cardiovascular Diseases

Table 1

MiRNA-155 and target genes in cardiovascular diseases.

Diseases	Target genes	References
CAD	SHIP1, HBP1, SOCS1, BCL6, CARHSP1, MAP3K10	[21–24, 30, 31]
AAA	AGTR1, CTLA4, SMAD2	[17, 35]
HF	TP53INP1	[41]
DBH	Ski, SnoN	[46]

AAA: abdominal aortic aneurysm; AGTR1: angiotensin II receptor 1; CAD: coronary arterial disease; DBH: diabetic heart; HF: heart failure; BCL6: B-cell lymphoma 6; CARHSP1: calcium-regulated heat stable protein; CTLA4: cytotoxic T-lymphocyte-associated protein 4; HBP1: HMG-box transcription factor 1; HGF: hepatocyte growth factor; MAP3K10: mitogen-activated protein kinase kinase kinase 10; SHIP1: SH2-containing inositol 5′-phosphatase 1; Ski: Sloan-Kettering Institute proto-oncogene; SMAD2: mothers against decapentaplegic homolog 2; SnoN: Ski-related novel gene, non-Alu-containing; SOCS1: suppressor of cytokine signaling 1; TP53INP1: tumor protein p53-inducible nuclear protein 1.